Global Fertility Supplements Market Report and Forecast 2023-2031

Global Fertility Supplements Market Report and Forecast 2023-2031


Global Fertility Supplements Market Outlook


The global fertility supplements market value in 2022 was USD 1.9 billion driven by the increasing awareness about fertility issues, rising infertility rates across the globe. The market size is anticipated to grow at a CAGR of 8.3% during the forecast period of 2023-2031 to achieve a value of USD 3.95 billion by 2031.

Fertility Supplements Introduction


Fertility supplements are dietary supplements designed to enhance fertility and increase the chances of conception in both men and women. These supplements are available in various forms, including pills, capsules, powders, and liquids, and are made up of a variety of ingredients, such as vitamins, minerals, herbs, and amino acids.

The global market for fertility supplements is expected to grow significantly in the coming years, driven by factors such as increasing awareness about fertility issues, rising infertility rates, and the growing popularity of natural and herbal supplements. The market is also expected to benefit from the growing trend towards delayed pregnancy, as more women are opting to have children later in life.

Key trends in the fertility supplements market include the increasing popularity of natural and organic supplements, the growing focus on male infertility, and the development of personalized fertility supplements tailored to individual needs. The market is also witnessing increasing demand for supplements that address specific fertility issues, such as polycystic ovary syndrome (PCOS) and endometriosis.

Fertility Supplements Market Scenario


Fertility supplements are natural or herbal supplements that can improve fertility in men and women by increasing sperm count, improving ovulation, and balancing hormones. These supplements are becoming increasingly popular as people seek alternative and complementary therapies for fertility issues. Fertility supplements are available over the counter and are often marketed as "natural" or "herbal" products.

The global fertility supplements market is growing rapidly due to increasing awareness and acceptance of natural and alternative treatments for infertility. The market is also driven by the growing prevalence of infertility and the desire to conceive among couples. The rising demand for natural and organic products, increasing healthcare expenditure, and the increasing adoption of fertility supplements among women are also contributing to the growth of the market.

However, the market is also facing challenges such as the lack of regulation and standardization of fertility supplements, the high cost of some supplements, and the presence of counterfeit products. Despite these challenges, the market is expected to continue growing in the coming years as more people seek natural and alternative therapies for fertility issues.

Fertility Supplements Market Segments


Market Breakup by Ingredient Type
  • Natural
  • Synthetic/Blend of Natural & Synthetic
Market Breakup by Product Type
  • Capsules
  • Tablets
  • Soft gels
  • Powders
  • Liquids
Market Breakup by Procedure
  • IVF with ICSI
  • IUI
  • Surrogacy
  • IVF without ICSI
  • Others
Market Breakup by End User
  • Fertility Clinics
  • Hospitals
  • Surgical Centers
  • Clinical Research Institutes
  • Others
Market Breakup by Distribution Channel
  • Over The Counter (OTC)
  • Prescribed
Market Breakup by Region
  • North America
  • United States of America
  • Canada
  • Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Others
  • Asia Pacific
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • Others
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Nigeria
  • South Africa
  • Others

Key Trends in the Fertility Supplements Market


Some key trends in the Fertility Supplements market are:
  • Increasing demand: Fertility supplements are becoming more popular as couples face difficulties in conceiving naturally. The market is expected to continue to grow due to rising awareness about fertility issues and increased acceptance of supplements.
  • Rising infertility rates: Infertility is a growing concern globally, with various factors such as increasing age, lifestyle changes, and medical conditions contributing to the rise. The fertility supplements market is expected to benefit from this trend.
  • Growing preference for natural supplements: Many couples are opting for natural supplements over prescription drugs and invasive procedures to improve their chances of conceiving. This trend is driving the growth of the fertility supplements market
  • Increasing product innovation: Fertility supplement manufacturers are developing new and innovative products that target specific fertility issues. These products are expected to contribute significantly to the growth of the market.
  • Growing e-commerce: The online sale of fertility supplements is growing, with consumers preferring the convenience of purchasing supplements from the comfort of their homes. This trend is expected to drive the growth of the market in the coming years.

Fertility Supplements Market: Competitor Landscape


The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
  • CARE Fertility
  • Xytex Corporation
  • FUJIFILM Irvine Scientific
  • INVO Bioscience
  • ALABAMA FERTILITY
  • Shivani Scientific
  • IVFtech Aps
  • WebMD LLC
  • Coast Science
  • Ocean Healthcare Private Limited
  • Genea Limited
  • Medicover AB
  • Monash IVF Australia
  • Progyny, Inc
  • Apollo Fertility
  • Carolinas Fertility Institute
  • Bayer AG
  • Zenith Nutrition
  • SUPPLEMENA
*Please Note:* The report will be completed in 7 business days after order confirmation


1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Fertility Supplements Market Overview
3.1 Global Fertility Supplements Market Historical Value (2016-2022)
3.2 Global Fertility Supplements Market Forecast Value (2023-2031)
4 Global Fertility Supplements Market Landscape
4.1 Global Fertility Supplements Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Fertility Supplements Product Landscape
4.2.1 Analysis by Product Type
4.2.2 Analysis by Technology
4.2.3 Analysis by End User
5 Global Fertility Supplements Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Fertility Supplements Market Segmentation
6.1 Global Fertility Supplements Market by Ingredient Type
6.1.1 Market Overview
6.1.2 Natural
6.1.3 Synthetic/Blend of Natural & Synthetic
6.2 Global Fertility Supplements Market by Product Type
6.2.1 Market Overview
6.2.2 Capsules
6.2.3 Tablets
6.2.4 Soft gels
6.2.5 Powders
6.2.6 Liquids
6.3 Global Fertility Supplements Market by Procedure
6.3.1 Market Overview
6.3.2 IVF with ICSI
6.3.3 IUI
6.3.4 Surrogacy
6.3.5 IVF without ICSI
6.3.6 Others
6.4 Global Fertility Supplements Market by End User
6.4.1 Market Overview
6.4.2 Fertility Clinics
6.4.3 Hospitals
6.4.4 Surgical Centers
6.4.5 Clinical Research Institutes
6.4.6 Others
6.5 Global Fertility Supplements Market by Distribution Channel
6.5.1 Market Overview
6.5.2 Over The Counter (OTC)
6.5.3 Prescribed
6.6 Global Fertility Supplements Market by Region
6.6.1 Market Overview
6.6.2 North America
6.6.3 Europe
6.6.4 Asia Pacific
6.6.5 Latin America
6.6.6 Middle East and Africa
7 North America Fertility Supplements Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Fertility Supplements Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Fertility Supplements Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Fertility Supplements Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Fertility Supplements Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Clinical Trials Analysis
14.1 Analysis by Trial Registration Year
14.2 Analysis by Trial Status
14.3 Analysis by Trial Phase
14.4 Analysis by Therapeutic Area
14.5 Analysis by Geography
15 Funding Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Regulatory Framework
17.1 Regulatory Overview
17.1.1 US FDA
17.1.2 EU EMA
17.1.3 INDIA CDSCO
17.1.4 JAPAN PMDA
17.1.5 Others
18 Supplier Landscape
18.1 CARE Fertility
18.1.1 Financial Analysis
18.1.2 Product Portfolio
18.1.3 Demographic Reach and Achievements
18.1.4 Mergers and Acquisitions
18.1.5 Certifications
18.2 Xytex Corporation
18.2.1 Financial Analysis
18.2.2 Product Portfolio
18.2.3 Demographic Reach and Achievements
18.2.4 Mergers and Acquisitions
18.2.5 Certifications
18.3 FUJIFILM Irvine Scientific
18.3.1 Financial Analysis
18.3.2 Product Portfolio
18.3.3 Demographic Reach and Achievements
18.3.4 Mergers and Acquisitions
18.3.5 Certifications
18.4 INVO Bioscience
18.4.1 Financial Analysis
18.4.2 Product Portfolio
18.4.3 Demographic Reach and Achievements
18.4.4 Mergers and Acquisitions
18.4.5 Certifications
18.5 ALABAMA FERTILITY
18.5.1 Financial Analysis
18.5.2 Product Portfolio
18.5.3 Demographic Reach and Achievements
18.5.4 Mergers and Acquisitions
18.5.5 Certifications
18.6 Shivani Scientific
18.6.1 Financial Analysis
18.6.2 Product Portfolio
18.6.3 Demographic Reach and Achievements
18.6.4 Mergers and Acquisitions
18.6.5 Certifications
18.7 IVFtech Aps
18.7.1 Financial Analysis
18.7.2 Product Portfolio
18.7.3 Demographic Reach and Achievements
18.7.4 Mergers and Acquisitions
18.7.5 Certifications
18.8 WebMD LLC
18.8.1 Financial Analysis
18.8.2 Product Portfolio
18.8.3 Demographic Reach and Achievements
18.8.4 Mergers and Acquisitions
18.8.5 Certifications
18.9 Coast Science
18.9.1 Financial Analysis
18.9.2 Product Portfolio
18.9.3 Demographic Reach and Achievements
18.9.4 Mergers and Acquisitions
18.9.5 Certifications
18.10 Ocean Healthcare Private Limited
18.10.1 Financial Analysis
18.10.2 Product Portfolio
18.10.3 Demographic Reach and Achievements
18.10.4 Mergers and Acquisitions
18.10.5 Certifications
18.11 Genea Limited
18.11.1 Financial Analysis
18.11.2 Product Portfolio
18.11.3 Demographic Reach and Achievements
18.11.4 Mergers and Acquisitions
18.11.5 Certifications
18.12 Medicover AB
18.12.1 Financial Analysis
18.12.2 Product Portfolio
18.12.3 Demographic Reach and Achievements
18.12.4 Mergers and Acquisitions
18.12.5 Certifications
18.13 Monash IVF Australia
18.13.1 Financial Analysis
18.13.2 Product Portfolio
18.13.3 Demographic Reach and Achievements
18.13.4 Mergers and Acquisitions
18.13.5 Certifications
18.14 Progyny, Inc
18.14.1 Financial Analysis
18.14.2 Product Portfolio
18.14.3 Demographic Reach and Achievements
18.14.4 Mergers and Acquisitions
18.14.5 Certifications
18.15 Apollo Fertility
18.15.1 Financial Analysis
18.15.2 Product Portfolio
18.15.3 Demographic Reach and Achievements
18.15.4 Mergers and Acquisitions
18.15.5 Certifications
18.16 Carolinas Fertility Institute
18.16.1 Financial Analysis
18.16.2 Product Portfolio
18.16.3 Demographic Reach and Achievements
18.16.4 Mergers and Acquisitions
18.16.5 Certifications
18.17 Bayer AG
18.17.1 Financial Analysis
18.17.2 Product Portfolio
18.17.3 Demographic Reach and Achievements
18.17.4 Mergers and Acquisitions
18.17.5 Certifications
18.18 Zenith Nutrition
18.18.1 Financial Analysis
18.18.2 Product Portfolio
18.18.3 Demographic Reach and Achievements
18.18.4 Mergers and Acquisitions
18.18.5 Certifications
18.19 SUPPLEMENA
18.19.1 Financial Analysis
18.19.2 Product Portfolio
18.19.3 Demographic Reach and Achievements
18.19.4 Mergers and Acquisitions
18.19.5 Certifications
19 Global Fertility Supplements Market - Distribution Model (Additional Insight)
19.1 Overview
19.2 Potential Distributors
19.3 Key Parameters for Distribution Partner Assessment
20 Key Opinion Leaders (KOL) Insights (Additional Insight)
21 Company Competitiveness Analysis (Additional Insight)
21.1 Very Small Companies
21.2 Small Companies
21.3 Mid-Sized Companies
21.4 Large Companies
21.5 Very Large Companies
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings